Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer
Wei Liu et al, 2020, OncoTargets and Therapy CrossRef
Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota Antonino Di Lorenzo et al, 2020, International Journal of Molecular Sciences CrossRef
Johnny on the Spot-Chronic Inflammation Is Driven by HMGB1 Carolina M. Gorgulho et al, 2019, Frontiers in Immunology CrossRef
Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice Jinguo Zhang et al, 2022, Frontiers in Immunology CrossRef
Severe Radiation-Induced Lymphopenia Affects the Outcomes of Esophageal Cancer: A Comprehensive Systematic Review and Meta-Analysis Dongjun Dai et al, 2022, Cancers CrossRef
Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death Joanna Kopecka et al, 2020, Cells CrossRef
Tumor-Promoting Activity and Proteomic Profiling of Cisplatin/Oxaliplatin-Derived DAMPs in Cholangiocarcinoma Cells Worawat Songjang et al, 2022, International Journal of Molecular Sciences CrossRef
Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy Bernardo Rapoport et al, 2019, International Journal of Molecular Sciences CrossRef
Ivermectin Enhanced Antitumor Activity of Resiquimod in a Co-Loaded Squalene Emulsion Zhongkun Zhang et al, 2022, Journal of Pharmaceutical Sciences CrossRef
High Mobility Group Box 1 in Human Cancer Bernardo L. Rapoport et al, 2020, Cells CrossRef
Hyaluronic Acid Nanoparticles for Immunogenic Chemotherapy of Leukemia and T-Cell Lymphoma Vinu Krishnan et al, 2022, Pharmaceutics CrossRef
Photothermal-Chemotherapy Integrated Nanoparticles with Tumor Microenvironment Response Enhanced the Induction of Immunogenic Cell Death for Colorectal Cancer Efficient Treatment Yayu Wen et al, 2019, ACS Applied Materials & Interfaces CrossRef
Adjuvant Antitumor Immunity Contributes to the Overall Antitumor Effect of Pegylated Liposomal Doxorubicin (Doxil®) in C26 Tumor-Bearing Immunocompetent Mice Takuma Takayama et al, 2020, Pharmaceutics CrossRef
Therapeutic Associations Comprising Anti-PD-1/PD-L1 in Breast Cancer: Clinical Challenges and Perspectives Fanny Ledys et al, 2021, Cancers CrossRef
Novel Methods to Overcome Acquired Resistance to Immunotherapy Xianda Zhao et al, 2019, Current Applications for Overcoming Resistance to Targeted Therapies CrossRef
Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango? Mohammad Hossein Kazemi et al, 2022, Frontiers in Immunology CrossRef
Effectiveness and Safety of the Traditional Chinese Medicine Treatment (HuoxueHuayu Therapy) for Malignant Tumors: A Systematic Review and Meta-Analysis Zehui Chen et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
Nanomedicine-Based Gene Delivery for a Truncated Tumor Suppressor RB94 Promotes Lung Cancer Immunity Sang-Soo Kim et al, 2022, Cancers CrossRef